Month: June 2021

Shoreline Biosciences and BeiGene Announce Global Strategic Collaboration to Develop and Commercialize Genetically Engineered Natural Killer (NK) Cell Therapies

SAN DIEGO & CAMBRIDGE, Massachusetts & BEIJING – (COMMERCIAL THREAD) – Shoreline Biosciences, Inc., a biotechnology company developing ready-to-use, standardized and targeted allogeneic cellular immunotherapies and cellular macrophages derived from induced pluripotent stem cells (iPSCs) for cancer and other serious diseases, and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160), a global biotechnology company, today announced an […]

Back To Top